Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,131.60
(
-0.27%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
93.93
(
1.61%
)
Bitcoin
74,430.94
(
-0.61%
)
News Focus
News Focus

Replies to post #185336 on Biotech Values

Replies to #185336 on Biotech Values
icon url

DewDiligence

01/01/15 2:35 PM

#185341 RE: iwfal #185336

BMY’s silence regarding plans for its 3-DAA regimen (#msg-108536151) suggests that BMY may not concur with Kolchinski’s “good enough” thesis for late-to-market HCV regimens.